Volume 17, Number 7—July 2011
Pandemic (H1N1) 2009 and Hajj Pilgrims Who Received Predeparture Vaccination, Egypt
Highlight and copy the desired format.
|EID||Kandeel A, Deming M, Abdel Kereem E, El-Refay S, Afifi S, Abukela M, et al. Pandemic (H1N1) 2009 and Hajj Pilgrims Who Received Predeparture Vaccination, Egypt. Emerg Infect Dis. 2011;17(7):1266-1268. https://dx.doi.org/10.3201/eid1707.101484|
|AMA||Kandeel A, Deming M, Abdel Kereem E, et al. Pandemic (H1N1) 2009 and Hajj Pilgrims Who Received Predeparture Vaccination, Egypt. Emerging Infectious Diseases. 2011;17(7):1266-1268. doi:10.3201/eid1707.101484.|
|APA||Kandeel, A., Deming, M., Abdel Kereem, E., El-Refay, S., Afifi, S., Abukela, M....El-Gabaly, H. (2011). Pandemic (H1N1) 2009 and Hajj Pilgrims Who Received Predeparture Vaccination, Egypt. Emerging Infectious Diseases, 17(7), 1266-1268. https://dx.doi.org/10.3201/eid1707.101484.|
In Egypt, vaccination against pandemic (H1N1) 2009 virus was required of pilgrims departing for the 2009 Hajj. A survey of 551 pilgrims as they returned to Egypt found 542 (98.1% [weighted]) reported receiving the vaccine; 6 (1.0% [weighted]) were infected with influenza virus A (H3N2) but none with pandemic (H1N1) 2009 virus.
The annual Hajj pilgrimage brings >2.5 million pilgrims from >160 countries to Mecca and Medina in Saudi Arabia during a 1-week period (1). In the past, 6.0%–9.8% of Hajj pilgrims with acute respiratory tract infection have been found to have influenza (2–4). Seasonal influenza vaccine is recommended for pilgrims by Saudi Arabia’s Ministry of Health (5), but vaccination coverage has been low (4,6).
The Hajj occurs during the twelfth month of the Islamic calendar, a lunar calendar that shifts 11 days earlier each year. The 2009 Hajj took place during November 25–28, (1430 AH), when the Northern Hemisphere was experiencing high pandemic (H1N1) 2009 virus activity, raising concern that the gathering could further contribute to the global spread of pandemic (H1N1) 2009. Health experts meeting in Jeddah in June 2009 made recommendations for reducing the pandemic’s effects during the Hajj (7). The value of predeparture vaccination was recognized, but it was thought unlikely that pandemic vaccine would be available in sufficient quantities to have a major effect on transmission during the Hajj. Egypt received the vaccine in time to begin vaccinating pilgrims on November 3, 2009, and required predeparture vaccination for all pilgrims to protect them against illness and reduce the importation of pandemic (H1N1) 2009 into Egypt when they returned. Egypt also enforced the Jeddah group’s recommendation that the 2009 Hajj pilgrimage be made only by persons 12–65 years of age.
Pandemic (H1N1) 2009 virus was first detected in Egypt in June 2009. It did not become the predominant influenza virus causing influenza-like illness (ILI) in Egypt’s ILI sentinel surveillance system until mid-November 2009 (8).
Approximately 80,000 Egyptians make the Hajj pilgrimage each year, usually returning to Egypt a few days to a few weeks after it. In all, 70%–80% of pilgrims arrive at Cairo International Airport or Port Tawfiq, near Suez (Ministry of Health, Egypt, unpub. data). During the peak return period, 7 or 8 flights arrive each day from Jeddah, with an average of 200–250 pilgrims per flight, and Port Tawfiq receives 1 ship per day from Jeddah with ≈1,000–1,200 pilgrims. The goal of the survey was to measure the prevalence of pandemic (H1N1) 2009 virus infection among returning pilgrims.
The survey was conducted by a team of 2 epidemiologists, 2 health workers, and 2 laboratory technicians from the Preventive Sector, Egyptian Ministry of Health, during the peak return period. Every tenth pilgrim on the ship from Jeddah arriving at Port Tawfiq on December 14, 2009, was selected for the survey sample without regard to illness status. At Cairo International Airport, pilgrims were selected from among all pilgrims on the 9 flights from Jeddah arriving during 9 AM–9 PM on December 10–12, 2009. Because the survey was conducted at the baggage-claim area, probability sampling proved to be difficult. With instructions to choose pilgrims throughout the area around the carousel without regard to age, sex, or illness status, the team selected a convenience sample of ≈50 pilgrims from each flight.
After providing verbal consent, pilgrims were asked their age, in which governorate they lived, and whether they had been vaccinated against pandemic (H1N1) 2009 virus. Their oropharynx was then swabbed, and swab specimens were placed in viral transport medium and kept in liquid nitrogen until transfer to the Ministry of Health’s Central Public Health Laboratory. All specimens were tested at the US Naval Medical Research Unit No. 3 in Cairo by real-time reverse transcription PCR (rtRT-PCR) for influenza A viruses, and all specimens positive for influenza A viruses were tested for influenza A subtypes, including pandemic (H1N1) 2009 virus, by rtRT-PCR, according to guidelines of the World Health Organization and the Centers for Disease Control and Prevention (Atlanta, Georgia, USA) (9). Testing was not performed for influenza B. A recent study found oropharyngeal swab samples to be more sensitive than nasopharyngeal swab samples for detecting pandemic (H1N1) 2009 virus by rtRT-PCR (10).
Results were weighted according to probabilities of selection within the ship and each plane, which were considered separate strata. Data were analyzed with PROC SURVEYFREQ in SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).
In all, 559 pilgrims were selected for the survey sample. Seven pilgrims refused to participate, and interview data were missing for 1 pilgrim, leaving 551 pilgrims in the analysis: 206 pilgrims from 4 flights on December 10, 219 pilgrims from 5 flights on December 12, and 126 pilgrims from the ship arriving December 14. The stated age of 549 (99.6%) of pilgrims in the sample was in the allowed age range of 12–65 years. Most were from the Cairo metropolitan area (43.8%) or Lower Egypt (51.0%); these areas were overrepresented compared with the proportion of the national population living in them (Table). All but 9 (98.1%) pilgrims reported receiving a predeparture vaccination against pandemic (H1N1) 2009 virus. No association was found between predeparture vaccination status and sex (p = 0.38), age (<55 years vs. >55 years) (p = 0.95), or area of residence (Cairo metropolitan area vs. outside this area) (p = 0.20). In all, 6 (1.0%, 95% confidence interval 0.2%–1.7%) pilgrims tested positive for influenza A. All had subtype H3N2. No pilgrim had positive results for pandemic (H1N1) 2009 virus.
This finding supports the conclusion that returning pilgrims likely contributed little to ongoing pandemic (H1N1) 2009 transmission in Egypt and is consistent with the intended effects of the predeparture vaccination requirement. At the time of the 2009 Hajj, pandemic (H1N1) 2009 was overwhelmingly the most common influenza virus in the Northern and Southern Hemispheres (12), and to our knowledge, few countries required predeparture vaccination against it. Thus, we expect that pilgrims were exposed to this virus during the Hajj, but the extent of exposure is uncertain. The only data of which we are aware that have been released thus far on the extent of such exposure were provided by the Minister of Health, Saudi Arabia, who announced on the last day of the Hajj that pandemic (H1N1) 2009 had been diagnosed in only 73 persons during the Hajj (5 of whom died) (13). Haworth et al. have argued that a much larger number of cases is likely, on the basis of the expected case-fatality ratio among the Hajj pilgrims and on modeling results (14).
Our survey had several limitations. First, the results may not apply to pilgrims who returned to Egypt before or after the survey period. Second, pilgrims from Lower Egypt and coastal Egypt were underrepresented in the survey sample. Third, convenience sampling was used to select pilgrims arriving by plane. Fourth, unvaccinated pilgrims may have been reluctant to tell interviewers they had not been vaccinated because predeparture vaccination was required. Finally, some pilgrims may have been infected with pandemic (H1N1) 2009 virus shortly before swab samples were obtained but were not yet shedding virus.
Egypt demonstrated that it could implement a predeparture vaccination requirement despite late arrival of the vaccine, and our survey found no evidence that pilgrims returned to Egypt with pandemic (H1N1) 2009 virus infection during the peak return period. These results may prompt other countries to consider a similar influenza vaccination policy before the Hajj and other mass gatherings where amplification of influenza virus transmission is a major threat. Studies of vaccine effectiveness, cost-effectiveness, and cost-benefit in these settings would provide additional useful information.
Dr Kandeel is undersecretary of preventive affairs in the Egyptian Ministry of Health. He has a long-standing interest in communicable disease prevention and control, including infection control in health facilities.
We thank the members of the Ministry of Health who assisted with the survey: Amany El-Shaeer for supervising field work, Quarantine Department members who obtained authorization for the survey, sanitarians who interviewed pilgrims and obtained swab specimens, and Central Public Health Laboratory staff for managing and transferring specimens. We also thank Engy Habashy and Mary Younan for conducting rtRT-PCR testing, Adel Azabfor for assisting with data management, and Marc-Alain Widdowson for reviewing the manuscript.
This evaluation was part of Egypt's public health practice response to pandemic (H1N1) 2009. It was reviewed by appropriate Centers for Disease Control and Prevention authorities and deemed not to be research in accordance with the federal human subjects protection regulations (45 Code of Federal Regulations 46.101c and 46.102d) and the agency’s Guidelines for Defining Public Health Research and Public Health Non-Research.
The Global Emerging Infections Surveillance and Response System of the US Department of Defense provided funding for laboratory testing.
- Hajj and 2009 pandemic influenza A H1N1. Lancet. 2009;374:1724.
- El-Sheikh SM, El-Assouli SM, Mohammed KA, Albar M. Bacteria and viruses that cause respiratory tract infections during the pilgrimage (Haj) season in Makkah, Saudi Arabia. Trop Med Int Health. 1998;3:205–9.
- Alborzi A, Aelami MH, Ziyaeyan M, Jamalidoust M, Moeini M, Pourabbas B, Viral etiology of acute respiratory infections among Iranian Hajj pilgrims, 2006. J Travel Med. 2009;16:239–42.
- Balkhy HH, Memish ZA, Bafaqeer S, Almuneef MA. Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination. J Travel Med. 2004;11:82–6.
- Ahmed AZ, Arabi YM, Memish ZA. Health risks at the Hajj. Lancet. 2006;367:1008–15.
- Shafi S, Rashid H, Ali K, El Bashir H, Haworth E, Memish ZA, Influenza vaccine uptake among British Muslims attending Hajj, 2005 and 2006. BMJ. 2006;333:1220.
- Ministry of Health. Saudi Arabia; World Health Organization (WHO); WHO Regional Office for the Eastern Mediterranean; US Centers for Disease Control and Prevention. International consultation: infectious disease prevention and control at Umra and Hajj (2009). Technical meeting. 5–7 Rajab, 1430 H, 28–30 June 2009, Jeddah Kingdom of Saudi Arabia [cited 2010 Mar 21]. http://www.emro.who.int/csr/h1n1/pdf/infectiousdiseases_hajj_umra.pdf
- Deming M, Kandeel A, Soliman A, Afifi S, Labib M, Teesdale S, Adding real-time epidemiological surveillance to virological influenza surveillance for vaccine planning: steps needed and public health value, Egypt, 2009–2010 [abstract]. International Conference on Emerging Infectious Diseases 2010 Slide Session Abstracts. Emerg Infect Dis. 2010 Jul 29 [cited 2010 Sep 16]. http://www.cdc.gov/eid/content/16/7/ICEID2010.pdf
- CDC protocol of realtime RTPCR for swine influenza A(H1N1). 28 April 2009, revision 1 (30 Apr 2009). Geneva: World Health Organization; 2009 [cited 2010 Mar 14]. http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/index.html
- Ahmed J, Eidex R, Njenga K, Nyoka R, Gichangi A, Mahamud A, Nasopharyngeal versus oropharyngeal specimens for the diagnosis of influenza, including 2009 pandemic influenza A (H1N1), using real time reverse transcriptase–polymerase chain reaction. International Conference on Emerging Infectious Diseases; July 11–14, 2010; Atlanta, GA, USA [cited 2011 Mar 8]. http://www.cdc.gov/eid/content/16/7/ICEID2010.pdf
- Central Agency for Public Moblization and Statistics. 2006 population, housing & establishments census. Governorates arranged in descending order by population size in 2006 census compared with 1996 census [cited 2010 Aug 3]. http://www.msrintranet.capmas.gov.eg/ows-img2/htms/pdf/finalpop/8.pdf
- FluNet, Global Influenza Surveillance Network. Global circulation of influenza viruses. Number of specimens positive for influenza by subtypes. Weeks 17 (2009)–5 (2010) from 19 April 2009 to 6 February 2010 [cited 2010 Apr 19]. http://www.who.int/csr/disease/swineflu/Virologicaldata2010_02_19.pdf
- Handeel Al-Shalchi. Saudi official: 5 dead from swine flu at Hajj. The Associated Press [cited 2010 Jul 10]. http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/index.html
- Haworth E, Rashid H, Booy R. Prevention of pandemic influenza after mass gatherings—learning from Hajj. J R Soc Med. 2010;103:79–80.
- Table. Demographic characteristics, vaccination history, and influenza A infection prevalence among 551 pilgrims returning from the Hajj, Egypt, 2009
Please use the form below to submit correspondence to the authors or contact them at the following address:
Michael Deming, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop F22, Atlanta, GA 30333, USA
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: August 18, 2011
- Page last updated: August 18, 2011
- Page last reviewed: August 18, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)